Industry commentators have welcomed Chancellor Philip Hammond's plans to support the growth of early-stage UK companies, as announced in last week's Budget, but some are sceptical about whether the changes could help raise significantly more capital through tax-efficient vehicles like EIS and VCTs.
The Chancellor launched the Patient Capital Review late last year in an attempt to overcome the barriers faced by young companies in the UK hoping to grow further. Chaired by Sir Damon Buffini, the...
Down 0.3% against the US dollar
Spent eight years at the firm
24-hour ping-pong with Legg Mason
May backs down on mutual regulatory recognition
Investing in commodity futures and stocks